Señales en vivo de AVCN.TO | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (6 may 2024 @ 15:59):

Avicanna Inc., a commercial-stage biopharmaceutical company, engages in the research and development of evidence-based products for consumer medical and pharmaceutical segments worldwide...

Stats
Volumen de hoy	41 604.00
Volumen promedio	114 428
Capitalización de mercado	30.69M
EPS	$0 ( 2024-04-01 )
Próxima fecha de ganancias	( $0 ) 2024-05-12
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-2.06
ATR14	$0.00100 (0.29%)

Volumen Correlación

Largo: -0.46 (neutral)

Corto: -0.20 (neutral)

Signal:(52.69) Neutral

AVICANNA INC Correlación

10 Correlaciones Más Positivas
SJR-B.TO	0.846
HGRO.TO	0.846
CEU.TO	0.845
SSF-UN.TO	0.841
MDA.TO	0.841
NVCN.TO	0.834
OLY.TO	0.827
PFMN.TO	0.827
HSAV.TO	0.82
LAM.TO	0.81

10 Correlaciones Más Negativas
SOY.TO	-0.908
IMV.TO	-0.868
PET.TO	-0.863
QSR.TO	-0.861
IMP.TO	-0.853
HUT.TO	-0.833
AII.TO	-0.83
EXE.TO	-0.828
CGY.TO	-0.825
HLF.TO	-0.824

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

AVICANNA INC Correlación - Moneda/Commodity

0.00
( neutral )

-0.03
( neutral )

AVICANNA INC Finanzas

Annual	2023
Ingresos:	$16.79M
Beneficio Bruto:	$6.58M (39.20 %)
EPS:	$-0.0931

FY	2023
Ingresos:	$16.79M
Beneficio Bruto:	$6.58M (39.20 %)
EPS:	$-0.0931

FY	2023
Ingresos:	$0
Beneficio Bruto:	$0 (0.00 %)
EPS:	$0

FY	2022
Ingresos:	$4.05M
Beneficio Bruto:	$1.12M (27.55 %)
EPS:	$-0.290

Financial Reports:

No articles found.

AVICANNA INC

Avicanna Inc., a commercial-stage biopharmaceutical company, engages in the research and development of evidence-based products for consumer medical and pharmaceutical segments worldwide. The company collaborates with Canadian academic and medical institutions. Its scientific platform includes research and development, and clinical development that leads to the commercialization of approximately twenty products across four main market segments. The company provides medical and wellness products containing cannabidiol, cannabigerol, and tetrahydrocannabinol under the RHO Phyto brand; functional CBD consumer derma-cosmetic and topical products under the Pura H&W and Pura Earth brand names; and cannabis dried flowers, standardized seeds, full spectrum extracts, cannabinoid distillates, isolated cannabinoids, and bulk formulations derived from hemp and cannabis cultivars under the Aureus brand. It also develops pharmaceutical products for epidermolysis bullosa, dermatology, chronic pain, and various neurological disorders. The company has research collaboration with Dr. Christine Allen'sResearch Group for the development of a cannabinoid-based treatment for lung inflammation associated with COVID19. Avicanna Inc. was incorporated in 2016 and is headquartered in Toronto, Canada.

Actualizaciones en tiempo real para AVICANNA INC [AVCN.TO]

Upcoming Earnings Alert